Open AccessA phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
Author(s) -
E. Claire Dees,
Bert H. O’Neil,
Celeste Lindley,
Frances A. Collichio,
Lisa A. Carey,
Jason Collins,
William Riordan,
Anastasia Ivanova,
Dixie Esseltine,
Robert Z. Orlowski
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/gmbp-hs07
Subject(s) - bortezomib , refractory (planetary science) , medicine , doxorubicin , pharmacology , liposome , oncology , chemotherapy , materials science , multiple myeloma , nanotechnology , composite material
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom